- ‘It’s caused a lot of tension in our marriage’: My wife’s family comes visit, hides food and never cleans up. How do we get rid of them?
- Barron's China’s AI Clout Might Be Overstated. What to Know.
- Barron's This Company Makes Costco and Amazon’s Store Brands. Its Stock Is a Buy.
- Barron's This Carbon-Capture Stock Has Big Plans. Why It’s a Buy.
- Barron's Forget Apple and Nvidia. Why June Belongs to Small-Caps.
- Barron's Market Gains as Wall of Worry Crumbles. What Happens Next.
- Judge in FTX bankruptcy rejects media challenge, says customer names can remain secret
- Barron's Commercial Traders Are Net Long Copper. That’s a Good Sign for the Red Metal.
- Mark Zuckerberg says Meta may be ‘primary beneficiary’ of Apple Vision Pro headset
- Biogen stock rallies after full-day halt as FDA panel recommends Alzheimer’s drug for approval
to be replaced
Daiichi Sankyo Co. Ltd.
¥ 4,909
Previous Close |
---|
¥4,740 |
Partner Center
Your Watchlists
Recently Viewed Tickers
Overview
4568 Overview
Key Data
- Open ¥4,831
- Day Range 4,806 - 4,934
- 52 Week Range 3,013 - 4,981
- Market Cap ¥9.09T
- Shares Outstanding 2.13B
- Public Float 1.63B
- Beta 0.88
- Rev. per Employee ¥77.681M
- P/E Ratio 86.26
- EPS ¥57
- Yield 0.69%
- Dividend ¥15
- Ex-Dividend Date Mar 30, 2023
- Short Interest N/A
- % of Float Shorted N/A
- Average Volume 4.18M
Performance
5 Day |
|
1 Month |
|
3 Month |
|
YTD |
|
1 Year |
|
Analyst Ratings
Recent News
Biotech and Pharma Why AstraZeneca Could Be a Sound Long-Term Bet
Bristol-Myers, Roche to study skin-cancer drugs
NEW YORK -(MarketWatch)- Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY, ROG.VX) agreed to study how a combination of their melanoma drugs work in treating patients with a specific genetic mutation.
T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda ...
T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda Pharmaceutical Co, Welcia Holdings Co
Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, ...
Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, Sells Fanuc Corp, Advantest Corp, Marui Group Co
Daiichi Sankyo Co. Ltd.
Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.
Competitors
Name | Chg % | Market Cap |
---|---|---|
Takeda Pharmaceutical Co. Ltd. | ¥7.05T | |
Chugai Pharmaceutical Co. Ltd. | ¥6.36T | |
Shionogi & Co. Ltd. | ¥1.8T | |
Sumitomo Pharma Co. Ltd. | ¥252.36B | |
Hisamitsu Pharmaceutical Co. Inc. | ¥285.24B |